Gnosis by Lesaffre launches phages-based ingredient line for gut health
The first product, developed from a new technological platform from Lesaffre that targets the main drivers of pathogen—induced digestive issues—is intended to fight pathogenic bacteria responsible for serious infections.
Gnosis by Lesaffre (Marcq-En-Baroeul, France) introduceda phages-based ingredient line to help target specific pro-inflammatory or pathogenic bacteria in the gut and potentially enhance the gastrointestinal benefits of probiotics.
“Consumers recognize probiotics and how they support our digestive health and overall health,” said Philippe Caillat, Gnosis by Lesaffre’sglobal marketing director, in a press release. “That’s what pushed us to continue exploring solutions for targeted digestive disorders, such as abdominal pain, diarrhea, and gut flora restoration. Good gut health truly is the essence of a good life. We’re here to bring that to life with our new phages-based portfolio.”
The first product, developed from a new technological platform fromLesaffrethat targets the main drivers of pathogen—induced digestive issues—is intended to fight pathogenic bacteria responsible for serious infections such as E.coli, Salmonella, and Listeria.
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.
